Crossmark

Phase I study of pegylated liposomal doxorubicin in combination with bortezomib for Japanese patients with relapsed or refractory multiple myeloma

Published Online: 2015-03-07

Published Print: 2015-06

Authors

Kusumoto, Shigeru

Sunami, Kazutaka

Inagaki, Mitsuo

Iida, Shinsuke
License Information

Text and Data Mining valid from 2015-03-07

Version of Record valid from 2015-03-07
More Information

Article History

Received: 12 December 2014

Revised: 25 February 2015

Accepted: 25 February 2015

First Online: 7 March 2015

Free to read: This content has been made available to all.

Document is current